ANAB vs VRTX: Which Stock is Better?
Side-by-side comparison of Anaptysbio Inc and Vertex Pharmaceuticals Inc in 2026
ANAB
Anaptysbio Inc
$55.67
VRTX
Vertex Pharmaceuticals Inc
$447.54
Key Metrics Comparison
| Metric | ANAB | VRTX | Winner |
|---|---|---|---|
| Market Cap | $1.69B | $110.97B | VRTX |
| P/E Ratio | N/A | 25.98 | VRTX |
| EPS (TTM) | $N/A | $16.83 | VRTX |
| Revenue Growth | -0.1% | 0.1% | VRTX |
| Gross Margin | 44.6% | 54.4% | VRTX |
Analyze ANAB
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANAB or VRTX a better investment?
Comparing ANAB and VRTX: Anaptysbio Inc has a market cap of $1.69B while Vertex Pharmaceuticals Inc has $110.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANAB and VRTX?
ANAB (Anaptysbio Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANAB or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANAB or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.1% for ANAB.
Which company is more profitable: ANAB or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 54.4% compared to 44.6% for ANAB.
Which is the larger company: ANAB or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.97B compared to $1.69B for ANAB.
Should I buy ANAB or VRTX in 2026?
Both ANAB and VRTX have investment merit. ANAB trades at $55.67 while VRTX trades at $447.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANAB and VRTX stock?
Key differences: Market Cap ($1.69B vs $110.97B), P/E Ratio (N/A vs 26.0x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (44.6% vs 54.4%).